Biohaven Pharmaceutical
BHVN
$40.51
Share price
-2.31%
Change (1 day)
185.08%
Change (1 year)
Categories
Biohaven Pharmaceutical (BHVN) - Cash on Hand
Cash on Hand as of December 2023 : $0.38 B
According to Biohaven Pharmaceutical
's latest financial reports the company has $0.38 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Biohaven Pharmaceutical - Cash on Hand chart (from 2021 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.38 B | -17.95% |
| 2022-12-31 | $0.46 B | 511.83% |
| 2021-12-31 | $76.05 M | -7.82% |
| 2020-12-31 | $82.5 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -45.47% | 🇺🇸 USA |